These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8899014)

  • 1. Progress in FDA pharmacosurveillance.
    Keller WC
    J Am Vet Med Assoc; 1996 Nov; 209(9):1546-7. PubMed ID: 8899014
    [No Abstract]   [Full Text] [Related]  

  • 2. Processing and evaluation of adverse drug experience reports at the Food and Drug Administration Center for Veterinary Medicine.
    Keller WC; Bataller N; Oeller DS
    J Am Vet Med Assoc; 1998 Jul; 213(2):208-11. PubMed ID: 9676589
    [No Abstract]   [Full Text] [Related]  

  • 3. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
    Miller DG
    Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary of adverse event reports for veterinary biologic products received by the USDA from 1999 through 2005.
    Frana TS; Elsken LA; Karli SA
    J Am Vet Med Assoc; 2006 Oct; 229(7):1100-2. PubMed ID: 17014356
    [No Abstract]   [Full Text] [Related]  

  • 5. Fort Dodge recalls ProHeart 6, citing FDA safety concerns. Advisory committee to review FDA findings.
    Kuehn BM
    J Am Vet Med Assoc; 2004 Oct; 225(8):1157-8. PubMed ID: 15521431
    [No Abstract]   [Full Text] [Related]  

  • 6. Veterinary medicines--suspected adverse reactions, 1997.
    Gray A
    Vet Rec; 1998 Jul; 143(3):60-1. PubMed ID: 9717219
    [No Abstract]   [Full Text] [Related]  

  • 7. Suspected adverse drug reactions in the Hungarian veterinary practice between 1982 and 1992.
    Bernáth S; Szászfai M; Kulcsár G; Halász M
    Acta Vet Hung; 1996; 44(4):451-6. PubMed ID: 9141281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA bans firms from importing and distributing contaminated animal drugs.
    J Am Vet Med Assoc; 1999 May; 214(10):1459. PubMed ID: 10340065
    [No Abstract]   [Full Text] [Related]  

  • 9. MedWatch, the new FDA adverse effects reporting system.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):303-4. PubMed ID: 8227487
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of suspected adverse reactions surveillance scheme.
    Skilton D
    Vet Rec; 2002 Feb; 150(7):223. PubMed ID: 11878447
    [No Abstract]   [Full Text] [Related]  

  • 11. APVMA veterinary pharmacovigilance program: suspected adverse experience reports for 2005.
    Linnett PJ
    Aust Vet J; 2006 Dec; 84(12):418-20. PubMed ID: 17156321
    [No Abstract]   [Full Text] [Related]  

  • 12. Veterinary medicines.
    Greet T
    Vet Rec; 2004 Feb; 154(9):276. PubMed ID: 15029970
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacovigilance in operation.
    Dean S
    J Small Anim Pract; 2005 May; 46(5):215. PubMed ID: 15909443
    [No Abstract]   [Full Text] [Related]  

  • 14. The United States Pharmacopeia Veterinary Practitioners' Reporting Program.
    Meyer EK; Becker SC
    J Am Vet Med Assoc; 1996 Feb; 208(3):361-3. PubMed ID: 8575965
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of adverse drug reaction reporting in veterinary and human medicine.
    Bukowski JA; Wartenberg D
    J Am Vet Med Assoc; 1996 Jul; 209(1):40-5. PubMed ID: 8926206
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawals of FDA-approved drugs raise questions.
    Mayo Clin Health Lett; 1998 Nov; 16(11):4. PubMed ID: 9809019
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring adverse reactions to veterinary drugs. Pharmacovigilance.
    Bataller N; Keller WC
    Vet Clin North Am Food Anim Pract; 1999 Mar; 15(1):13-30, vii-viii. PubMed ID: 10088209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEDWatch: the new FDA medical products reporting program.
    Kessler DA
    Clin Pharm; 1993 Jul; 12(7):529-32. PubMed ID: 8354041
    [No Abstract]   [Full Text] [Related]  

  • 20. Journals, FDA announce steps to encourage ADR reporting.
    Thompson CA
    Am J Hosp Pharm; 1994 Apr; 51(8):966-8, 974. PubMed ID: 8037224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.